Despite significant advances in understanding the neurobiology of schizophrenia, treatment options have largely remained limited. But in 2023, four late-stage clinical trial readouts in schizophrenia could offer a new glimmer of h
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,